Aspirin Category Intelligence
Report Coverage
- Market Analysis
- Value Chain Analysis
- Price and Cost Analysis
- Price Trend Analysis
Production Size
Global Production Size/ Capacity
28 KT (2020)
Aspirin Market Trends
Category Intelligence on Aspirin covers the following
- Information relating to market, supply, cost, and pricing analysis
- Hard to find data on cost and TCO models, supplier details, and performance benchmarks
- Macroeconomic and regional trends impacting cost, supply, and other market dynamics
- Category-specific negotiation and sourcing advice
Want a more detailed personalised report?
Industry Outlook & Drivers
Aspirin Global Market Outlook:
Global market size – 28 KT (2020)
Expected to grow at a CAGR of 6 percent
Market Trends:
Aspirin manufactures are increasing capacity, in response to
the increasing demand of the market.
Porter's Analysis on Aspirin
Supplier Power
- The market of Salicylic Acid used in the manufacture of Aspirin is fragmented with many players available in the market
- Some of the key market players also have salicylic acid in their product portfolio
- Salicylic Acid is majorly used in pharmaceutical manufacturing. The demand from other industries is minimal
- Hence, the suppliers of Aspirin raw materials has lower power
Barriers to New Entrants
- Consolidated Market: The Aspirin API market is consolidated with the top three players, holding close to 70 percent of the market share
- The top players have all the required regulatory certifications and an established consumer base
- Capital investment and competition are the major barriers for the new entrants in the market
Intensity of Rivalry
- Consolidated Market: As the marker is consolidated, each of the regulated suppliers have significant marker share. Hence, there is no problem of price competition
- Capacity Expansion: The established suppliers have been increasing their manufacturing capacities in response to the growing market demand
Threat of Substitutes
- Aspirin, being used for a wide range of indications, has lower risk of substitution, due to the low toxicity profile and established usage among the health care professionals
- However, the novel molecules, being introduced in the market for cardio vascular indication, etc., could effect the market size
Buyer Power
- The buyer has medium power, since the market is consolidated with lower number of regulated suppliers and their high market share
